Panel
Sarah Fryer is a Director on the Board of the ICR, a membership-led, not for profit, independent association for clinical research professionals, in commercial and non-commercial environments.
The ICR has three guiding principles: Developing Professionals; Sharing Knowledge; and Raising Standards. It promotes good relations with other healthcare related groups, including the BIA, and provides:
Sarah has worked in clinical development for more than 30 years, with the last 20 years focusing on clinical QA. The majority of her career has been spent working in contract research and consultancy roles, supporting early phase biopharma companies as they move from research into clinical development. She was co-founder of Gregory Fryer Associates and founder of QRC Consultants and is now working as an independent GCP QA consultant as Director of Green End Barns Consulting Ltd.
She has been a long term member of the ICR and is also a Fellow of the Research Quality Assurance and a member of the Royal Society of Biology.
Her particular interest is the importance of quality and regulatory compliance in clinical research and brings this interest with enthusiasm to her role on the Board of the ICR.
Roland has served as Chief Executive of Cambridge University Hospitals NHS Foundation Trust (CUH) since 2015.
The trust is a high performing centre for clinical care and patient experience, running the UK's most digitally developed hospitals and making award-winning use of digital systems to improve patient care. From 2018 to 2021, he was the accountable officer for the integrated care system in Cambridgeshire and Peterborough. The integrated care system and the hospital trust are focused on innovation and improvement, working alongside universities and industry to deliver this.
Aligned with these roles, Roland chaired the Shelford Group of ten teaching hospitals from 2020–2023; and in March 2023 was appointed as the NHS England National Director for Life Sciences. This position works alongside the Innovation, Research and Life Sciences (IRLS) team in NHSE to engage national innovation partners, local systems, industry, and research charities to develop a clear blueprint for how the NHS can best support, and benefit from, a strong life sciences ecosystem. During March 2023 Roland became a Governor of The Health Foundation, focussed on innovation and life sciences.
Before joining CUH, Roland was Chief Executive, Chief Operating Officer and Strategy Director at King’s College Hospital NHS Foundation Trust. He began his career in the field of corporate law at Linklaters, based in London and Hong Kong, and later moved to McKinsey to work in strategy consultancy.
Before joining Stevenage Bioscience Catalyst (SBC) in 2022, Marco spent three years at alternative-protein start-up, Better Dairy, having joined the founders as their first hire. As Head of R&D, he led the science team and helped the start-up grow from pre-seed to £22m Series A investment. As Innovation Lead, he organised and managed the building of a new lab and office facility in East London and helped devise new scientific strategies.
Marco holds a BSc and MSc in Biomedical Engineering with a focus on data science. He also holds a PhD in Synthetic Biology with a focus on protein design. Before joining Better Dairy, he was part of the Entrepreneur First programme.
